Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» IMPAX Receives Final FDA Approval For Generic SOLODYN Extended-Release Tablets, 45mg, 90mg And 135mg
IMPAX Receives Final FDA Approval For Generic SOLODYN Extended-Release Tablets, 45mg, 90mg And 135mg
IMPAX Receives Final FDA Approval For Generic SOLODYN Extended-Release Tablets, 45mg, 90mg And 135mg
Submitted by
admin
on February 8, 2009 - 12:22pm
Source:
Medical News Today
News Tags:
Impax
Headline:
IMPAX Receives Final FDA Approval For Generic SOLODYN Extended-Release Tablets, 45mg, 90mg And 135mg
Do Not Allow Advertisers to Use My Personal information
